Fluidigm, GenomOncology Partner to Create Integrated Workflow for Immuno-Oncology Research

September 8, 2018

Fluidigm and GenomOncology announced today that they have partnered to create what they’re calling the Immuno-Oncology Gene Expression Workflow, with the goal of accelerating the development of checkpoint immunotherapies and the identification of potential predictive biomarker signatures for therapeutic response.

Read more…